Last week was a busy one for makers of diabetes devices, with the FDA expanding the approval of Dublin-based Medtronic plc's Minimed 670G hybrid closed looped system, and San Diego's Tandem Diabetes ...

Developers of insulin delivery systems Insulet Corporation (NASDAQ:PODD) and Tandem Diabetes Care (NASDAQ:TNDM) traded lower on Thursday after their rival Medtronic (MDT) agreed to acquire EOFlow Co.

About half a year after announcing its intent to acquire a South Korean maker of tubeless insulin pump technology, Medtronic is scrapping the deal. In an 8-K filing (PDF) with the U.S. Securities and ...

Using an insulin pump is an act of profound trust. Diabetic patients wear their insulin pumps at virtually all hours, relying on the medical machinery to administer doses of a potentially lethal ...

Medtronic devices comprise an estimated 60% of the insulin pump market. Image: Medtronic Medical device maker Medtronic has expanded its recall of remote controllers for its MiniMed 508 and MiniMed ...

Medtronic is recalling remote controllers used with its MiniMed 508 insulin pump and MiniMed Paradigm family of insulin pumps due to dangerous security flaws. The Food and Drug Administration on ...

Two years after submitting the latest version of its insulin pump technology for FDA approval—and three years after it was first made available in Europe—Medtronic has finally secured the agency’s ...

Medtronic is urgently recalling remote controllers for insulin pumps belonging to the ‘MiniMed Paradigm’ family of products, due to severe cybersecurity risks. The controllers that should be returned ...

Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support "Our goal is to simplify diabetes management and ...

The Centers for Disease Control and Prevention (CDC) state that in the last 20 years, the number of adults diagnosed with diabetes has more than doubled. The primary treatment for type 1 diabetes is ...

Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...